Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Hidradenitis suppurativa, a chronic skin disease, can be managed with antibiotics, lifestyle changes, and in severe cases, surgery. Early diagnosis and careful planning are key, and laser treatment can be an efficient solution for mild to severe cases.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Spironolactone plus finasteride reduces hirsutism more effectively.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Spironolactone may help enlarge a small breast linked to Becker's nevus.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.